Transient Anisocoria Secondary to Nebulized Ipratropium Bromide

1. Gross NJ . Ipratropium bromide. N Enagl J Med. 1988;319:486-494.

2. Helfaer MA , Nichols DG , Chantarojanasiri r , Rogers MC . Lower airway disease: broniolitis and asthma. In: Rogers MC , ed. Pediatric Intensive Care. Baltimore: Williams and Wilkins; 1992:258-295.

3. Helprin GA , Clarke GM . Unilateral fixed dilated pupil associated with nebulized ipratropium bromide. Lancet. 1986;ii:1469-1469.

4. Samaniego F , Newman LS . Migratory anisocoria-a novel clinical entity. Am Rev Respir Dis. 1986;134: 844-844.

5. Mulpeter KM , WalshJB, O ' Connor M , et al. Ocular hazards of nebulized bronchodilators. Postgrad Med. 1992;68:132-133.

6. Hoffman BB , Lefkowitz RJ , Taylor P . Neurotransmission: the autonomic and somatic motor nervous systems. In: Hardman JG , Limbird LE , Molinoff TB , et al, eds. The Pharmacologic Basis of Therapeutics. New York: McGraw-Hill; 1996:105-140.

7. Wade TA , Watson MD , Shuckett P , et al. Effect of nebulized ipratropium bromide on intraocular pressures in children. Chest. 1994;105:1439-1441.

8. Farrow PR , Fancourt GJ . Does ipratropium bromide by nebulizer and face mask have local ocular effects? Hum Toxicol. 1986;5:53-54.

9. Jannun DR , Mickel SF . Anisocoria and aerosolized anticholinergics. Chest. 1986;90:148-149.